Pattern of release and relationship between HMGB-1 and IL-6 following blunt trauma.
BACKGROUND
High mobility group box-1 (HMGB-1), a recently identified inflammatory cytokine, is implicated in the pathogenesis of several inflammatory, infective and neoplastic processes. Patterns of expression following blunt trauma have not been adequately reported in the literature. This study aimed to quantify the serum concentrations of HMGB-1 following blunt trauma, and assess its relationship with the more established interleukin 6 (IL-6).


METHODS
20 patients with median injury severity score 17 (range 9-36) sustaining closed diaphyseal fractures of the femur treated by intramedullary nailing were included in the study. Serum concentrations of HMGB-1 and IL-6 were measured at several time points during their treatment.


RESULTS
A strong correlation was observed between admission and day 1 post-op concentrations of IL-6 and both the injury severity score (ISS) and the requirement for intensive care unit treatment. Serum concentrations of HMGB-1 did not demonstrate such a correlation. Around day 3 when IL-6 concentrations begin to fall, serum HMGB-1 concentrations were observed to increase.


CONCLUSIONS
IL-6 concentration measured early after admission is again shown to be strongly associated with overall injury severity and requirement for intensive care unit treatment. In contrast, HMGB-1 appears to be a late inflammatory mediator with levels becoming elevated once serum concentrations of IL-6 begin to fall. However, we were unable to demonstrate any relationship with injury severity or requirement for ICU care at any stage. These preliminary findings may form the basis for future research in this area.
Giannoudis
Peter V
PV
Academic Department of Trauma & Orthopaedic Surgery, LIMM Section Musculoskeletal Disease, School of Medicine, University of Leeds, UK.
Mallina
Ravi
R
Harwood
Paul
P
Perry
Sarah
S
Sante
Emilio Delli
ED
Pape
Hans Christoph
HC
D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D003422:Critical Care; D005260:Female; D005264:Femoral Fractures / Q000097:blood* / Q000276:immunology; D024243:HMGB1 Protein / Q000097:blood* / Q000276:immunology; D006801:Humans; D015601:Injury Severity Score; D015850:Interleukin-6 / Q000097:blood* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D018805:Sepsis / Q000097:blood* / Q000209:etiology / Q000276:immunology; D013997:Time Factors; D014949:Wounds, Nonpenetrating / Q000097:blood* / Q000150:complications / Q000276:immunology; D055815:Young Adult
D024243:HMGB1 Protein; D015850:Interleukin-6